rubella virus vaccine live
Trade name: Meruvax
Approved
Jun 9, 1969
Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child-bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated. By introducing rubella containing vaccines, rubella has been eradicated in 81 nations, as of mid-2020. — Wikipedia
Clinical trial activity
3 trials · 7 clinical orgs · 1 marketing orgs
Earliest trial started Jul 1, 2011 (NCT02724852)
Timeline
Indications
Approved for
Mechanism of action
- Rubella virusImmunity, active
Rubella virus immunity, active
Approval history
- approvedJun 9, 1969
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRubella vaccine ↗
- ChEMBLCHEMBL2109225 ↗
Also known as
- meruvax
- rubella vaccine
- rubella virus vaccine live
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04394689 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2020 | Centers for Disease Control and Prevention (CDC), Government of the Gambia, Medical Research Council, Micron Biomedical, Inc |
| NCT02196285 | Phase 1 | Sep 1, 2015 | Bill and Melinda Gates Foundation, Oswaldo Cruz Foundation |
| NCT02724852 | Phase 4 | Jul 1, 2011 | Chiangmai University |
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2020 |
| Chiangmai University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Government of the Gambia | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Medical Research Council | Government | 1 | 0 | 1 | 2020 |
| Micron Biomedical, Inc | For profit | 1 | 1 | 1 | 2020 |
| Oswaldo Cruz Foundation | Academic/Hospital | 1 | 1 | 1 | 2015 |